Maleiimide anti-tumor phosphatase inhibitors
US7504430B2 · kind B2 · utility
4Cited by
1References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 22, 2006 |
| Grant date | Mar 17, 2009 |
| Priority date | — |
| Expiry date | Feb 3, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention features maleiimide compounds, pharmaceutical compositions of maleiimide compounds and methods of treating a patient suffering from cancer, the method comprising administering to a patient one or more maleiimide compounds of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.